These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11714130)

  • 1. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
    Gibbs CR; Blann AD; Edmunds E; Watson RD; Lip GY
    Clin Cardiol; 2001 Nov; 24(11):724-9. PubMed ID: 11714130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
    Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
    Chin BS; Blann AD; Gibbs CR; Chung NA; Conway DG; Lip GY
    Eur J Clin Invest; 2003 Nov; 33(11):941-8. PubMed ID: 14636296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
    Chin BS; Conway DS; Chung NA; Blann AD; Gibbs CR; Lip GY
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):515-21. PubMed ID: 12960603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism.
    Palka I; Nessler J; Nessler B; Piwowarska W; Tracz W; Undas A
    Heart; 2010 Jul; 96(14):1114-8. PubMed ID: 20610458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
    Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
    Goldsmith IR; Blann AD; Patel RL; Lip GY
    Am J Cardiol; 2000 May; 85(10):1218-22. PubMed ID: 10802004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.